Skills

Health & Biomedicine

At Leitat, we offer innovative scientific-technological solutions for the chemical, veterinary, biotechnological and pharmaceutical sectors, driving the transformation and advancement of the industry with experience and commitment.

skills

Health & Biomedicine

At Leitat, we offer innovative scientific-technological solutions for the chemical, veterinary, biotechnological and pharmaceutical sectors, driving the transformation and advancement of the industry with experience and commitment.

WE'RE HERE TO HELP

  • In vitro cell models to study the efficacy, safety, mechanism of action, screening, ADME-Tox, bioanalysis, metabolomics, etc., of drugs, cosmetics, regenerative health products and food supplements.
  • In vivo models to study efficacy, combi-therapy, immuno-oncology, biodistribution, pre-Tox and Maximum Tolerated Doses (MTD), pre-PK, histology, etc. (oncology, inflammation, dermatology, neurodegeneration, cell and tissue regeneration, angiogenesis).
  • Generation of on-demand polyclonal and monoclonal antibodies (mAbs) for basic research, diagnosis and  therapeutic treatments.
  • Antibody engineering: Antibody Drug Conjugates (ADC), VHH single domain (nano) antibodies, Bispecific  Antibodies, Chimerization, Humanization, Antibody fragments (Fab, scFv), Phage Display Libraries and biosimilars.
  • In vivo models for microbiome, dysbiosis and human microbiota transplant studies. Collaboration in the  development of probiotics and prebiotics for nutrition and treatment of diseases.
  • In vivo models of osteoarticular injuries – musculoskeletal, cartilage, tendon, ligament, small and  large animals, combined with imaging studies (CT, MRI).

Human capital

  • Multidisciplinary team, scientific-technical background, industrial approach.
  • Biologists, biotechnologists, bioengineers, biochemists, pharmacists.
  • Preclinical drug development and advanced therapies.
  • Research and validation of diagnostic biomarkers.
  • Antibody development and engineering.

Resources and infrastructure

  • Phage lab (phage display).
  • Monoclonal antibody lab.
  • Dermo-cosmetics/dermatology lab.
  • Stem cells (IPSC, mesenchymal).
  • Organoid bank.
  • Advanced models for Oncology, CNS, IBD and osteoarticular pathologies.
  • Bioprinting.
  • In vivo microbiome models.
  • Full access to the Barcelona Science Park infrastructure: genomics, animal science, proteomics, microscopy, etc.
  • ISO13485 certification for the design and development of medical and diagnostic products in vitro (including software).
Diagnostics & Medical Technologies
Pharmacy & Veterinary

Quality Management System for Medical Devices (UNE-EN ISO 13485:2018 Standard)

See more certifications
CONTACT US
MORE INFO
Marc Masa

Marc Masa

Head of Health & Biomedicine

Marc Masa is a biologist specializing in preclinical oncology, with more than 25 years of research experience in the private sector, including the pharmaceutical industry. His work focuses on drug and biomarker discovery in oncology. He is a co-author of several patents and has published scientific articles in leading journals. He has also undertaken numerous research projects. He is currently the director of the Department of Health and Biomedicine at Leitat.

Linkedin Envelope

NOTEWORTHY PROJECTS

ONCOSOMIX

ONCOSOMIX

HERACLES

HERACLES

KLEBSIELLA

KLEBSIELLA

ADC-CRC

ADC-CRC

BIOWASHEETS

BIOWASHEETS

HPK1-INHIB

HPK1-INHIB

Last news